Results 151 to 160 of about 32,341 (221)

Erratum: Subacute brainstem ischemic syndrome in juvenile neurofibromatosis type 2: An under-recognized condition. [PDF]

Clin Case Rep, 2023
Blauen A, Lenfant C, Duprez T, Nassogne MC.   +3 more
europepmc   +1 more source

P13.26 * LINEAR ACCELERATOR RADIOSURGERY FOR THE TREATMENT OF NEUROFIBROMATOSIS TYPE 2 RELATED VESTIBULAR SCHWANNOMAS [PDF]

, 2014
Oksana Zemskova, Olga Chuvashova
openalex   +1 more source

Neurofibromatosis Type 2: A Rare Case of Multiple Intracranial Schwannomas, Meningiomas, and Ependymomas (MISME) Syndrome and Literature Review. [PDF]

Cureus
Hamza L, Yahya N, Wafa H, Loubna C, Sara L, Nawal A.   +5 more
europepmc   +1 more source

Subacute brainstem ischemic syndrome in juvenile neurofibromatosis type 2: An underrecognized condition. [PDF]

Clin Case Rep, 2022
Blauen A, Lenfant C, Duprez T, Nassogne MC.   +3 more
europepmc   +1 more source

Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2: a systematic review and meta-analysis. [PDF]

BMC Cancer
Hajikarimloo B, Tos SM, Alvani MS, Kooshki A, Mohammadzadeh I, Habibi MA.   +5 more
europepmc   +1 more source

Cochlear implant in a patient with neurofibromatosis type 2 undergoing radiotherapy

, 2015
Patrícia Santos Pimentel, Danielle Seabra Ramos, Lílian Ferreira Muniz, Mariana de Carvalho Leal Gouveia, Sílvio da Silva Caldas Neto   +4 more
openalex   +1 more source

FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas [PDF]

, 2013
Silvia Licciulli, Jasna Maksimoska, Chun Zhou, Scott Troutman, Smitha Kota, Qin Liu, Sergio G. Durón, David A. Campbell, Jonathan Chernoff, Jeffrey Field, Ronen Marmorstein, Joseph L. Kissil   +11 more
openalex   +1 more source

Management Strategies of Neurofibromatosis Type 2 in Pediatric Patients : Challenges and Emerging Therapies. [PDF]

J Korean Neurosurg Soc
Lee JS.
europepmc   +1 more source

Vestibular dysfunction in neurofibromatosis type 2-related schwannomatosis. [PDF]

Brain Commun, 2023
Madhani AS, King S, Zhu J, Karmali F, Welling DB, Cai W, Jordan JT, Lewis RF.   +7 more
europepmc   +1 more source

Management of Bevacizumab-Induced Proteinuria Using an Angiotensin Receptor Blocker (ARB) in a Neurofibromatosis Type 2 (NF-2) Patient With Vestibular Schwannoma. [PDF]

Cureus, 2023
Omene EE, Easaw J.
europepmc   +1 more source